{"entity":{"type":"insider","cik":"0001727756","url":"/insider/0001727756","json_url":"/insider/0001727756.json","name":"Stuart Iain","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2018-08-09","last":"2019-07-03","span_basis":"filed_date"},"name_variants":[{"name":"Stuart Iain","source":"filing","n_filings":4,"first_seen":"2018-08-09","last_seen":"2019-07-03"}],"transactions":[{"id":8067500,"accession":"0001209191-19-041101","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-041101","line_url":"/filing/0001209191-19-041101#line-1","is_derivative":false,"issuer_cik":"0001606645","issuer_name":"Foamix Pharmaceuticals Ltd.","issuer_ticker":"FOMX","issuer_name_source":null,"issuer_url":"/issuer/0001606645","owner_cik":"0001727756","owner_name":"Stuart Iain","owner_url":"/insider/0001727756","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":951.0,"shares_display":"951","price_per_share":2.35,"price_display":"2.35","price_state":"stated","total_value":2234.85,"total_display":"2,234.85","shares_owned_after":63524.0,"shares_owned_after_display":"63,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-01","filed_date":"2019-07-03","scope":"insider"},{"id":7876380,"accession":"0001209191-19-023170","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-023170","line_url":"/filing/0001209191-19-023170#line-1","is_derivative":false,"issuer_cik":"0001606645","issuer_name":"Foamix Pharmaceuticals Ltd.","issuer_ticker":"FOMX","issuer_name_source":null,"issuer_url":"/issuer/0001606645","owner_cik":"0001727756","owner_name":"Stuart Iain","owner_url":"/insider/0001727756","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1696.0,"shares_display":"1,696","price_per_share":3.75,"price_display":"3.75","price_state":"stated","total_value":6360.0,"total_display":"6,360.00","shares_owned_after":64475.0,"shares_owned_after_display":"64,475","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-01","filed_date":"2019-04-03","scope":"insider"},{"id":6578295,"accession":"0001178913-18-002900","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-18-002900","line_url":"/filing/0001178913-18-002900#line-1","is_derivative":false,"issuer_cik":"0001606645","issuer_name":"Foamix Pharmaceuticals Ltd.","issuer_ticker":"FOMX","issuer_name_source":null,"issuer_url":"/issuer/0001606645","owner_cik":"0001727756","owner_name":"Stuart Iain","owner_url":"/insider/0001727756","role":"Officer (SVP R&D)","officer_title":"SVP R&D","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":683.0,"shares_display":"683","price_per_share":4.58,"price_display":"4.58","price_state":"stated","total_value":3128.14,"total_display":"3,128.14","shares_owned_after":33602.0,"shares_owned_after_display":"33,602","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-08","filed_date":"2018-11-13","scope":"insider"},{"id":6193598,"accession":"0001178913-18-002363","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-18-002363","line_url":"/filing/0001178913-18-002363#line-1","is_derivative":false,"issuer_cik":"0001606645","issuer_name":"Foamix Pharmaceuticals Ltd.","issuer_ticker":"FOMX","issuer_name_source":null,"issuer_url":"/issuer/0001606645","owner_cik":"0001727756","owner_name":"Stuart Iain","owner_url":"/insider/0001727756","role":"Officer (SVP R&D)","officer_title":"SVP R&D","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2715.0,"shares_display":"2,715","price_per_share":5.68,"price_display":"5.68","price_state":"stated","total_value":15421.2,"total_display":"15,421.20","shares_owned_after":34285.0,"shares_owned_after_display":"34,285","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-08","filed_date":"2018-08-09","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001606645","name":"Foamix Pharmaceuticals Ltd.","url":"/issuer/0001606645","role":"Officer (Chief Scientific Officer)","n_filings":4,"first_seen":"2018-08-09","last_seen":"2019-07-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001727756","retrieved_at":"2026-08-21T03:28:13+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}